Current Opinion in Organ Transplantation was launched in 1996. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of organ transplantation is divided into 18 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.
Parsia A. Vagefi
Dr Parsia A. Vagefi graduated with a B.A. in Biology from Johns Hopkins University, followed by medical school at Yale. During medical school, Dr Vagefi was a HHMI Research Fellow at MGH under the direction of Dr David Sachs, where he investigated large animal models of allograft and xenograft tolerance. Dr Vagefi returned to MGH for his general surgery residency, followed by transplant surgery fellowship at UCSF where he was awarded the American Society of Transplant Surgery Novartis Fellowship in Transplantation for his clinical research with Dr Sandy Feng, investigating operational tolerance in recipients of simultaneous liver and kidney transplants. In 2011, Dr Vagefi joined the MGH staff, eventually serving as Associate Surgical Director of Liver Transplantation and Surgical Director of Living Donor Liver Transplantation. Dr Vagefi also held an appointment as a Senior Investigator at the Center for Transplantation Sciences, establishing an effort focused on the clinical application of liver xenotransplantation- with his group having now achieved the world's longest survival of a pig liver in a non-human primate. In January 2018, Dr Vagefi joined the UT Southwestern team as Chief, Division of Surgical Transplantation, and currently holds the Ernest Poulos, MD Distinguished Chair in Surgery.
Dr Giuseppe Orlando hails from Rome, Italy, where he attended medical school and received training in general surgery and transplantation. He also participated in clinical fellowships in Paris (200) and Brussels (2001–2004). Between 2006–2008, he was a practicing transplant surgeon at the University of L’Aquila, Italy. Between 2008–2011, he was the recipient of the distinguished Marie Curie International Outgoing Fellowship through the European Commission Framework Program. During this time, he specialized in regenerative medicine (RM) and transplant immunology at the Wake Forest Institute for Regenerative Medicine in Winston Salem, USA, and the Transplant Research Immunology Group, University of Oxford, UK.
At first, his research focus was immunosuppression-free transplantation. More recently, his research focus has shifted towards RM and aims at developing strategies and platforms for the bio-engineering, regeneration and repair of abdominal organs, as well as at supporting the idea that organ bio-engineering and regeneration should become the new Holy Grail for modern transplantation. He has been successful in developing clinically relevant models for organ bio-engineering consisting of scaffolds produced through the decellularization of porcine or human organs. He has been instrumental in popularizing the concept of recycling discarded human organs for tissue engineering purposes and is currently proposing the use of discarded human kidneys and pancreas as platforms for kidney and endocrine pancreas bio-engineering and regeneration. As a culmination of his body of work to date, he has published the first two books bridging RM to organ transplantation – Regenerative Medicine Technologies Applied to Organ Transplantation and Kidney Transplantation, Bioengineering and Regeneration – and is currently preparing two more books, Transplantation, Bioengineering and Regeneration of the Endocrine Pancreas and Organ Repair: Ischemia Reperfusion and Organ Preservation in the Regenerative Medicine Era. In recognition of the above work, he was the 2017 ASTS Rising Star in Transplantation Award.
Giuseppe is a member of numerous transplant and RM societies and committees, is the chair (2019–2020) of the AST Regenerative Medicine COP, is counselor of IPITA (2019–2023) and co-chair of the GI Committee of the International Society for Cell and Gene Therapy, is on the board and acts as regular reviewer for a number of relevant journals and funding agencies, is in the advisory board of SERAXIS, INC., and is a regular lecturer at national and international conferences, workshops and symposia. Overall, he has authored or co-authored more than 200 papers and book chapters, 80 of which focusing on RM applied to organ transplantation.
Dr Henrik Petrowsky is Professor of Surgery and Vice Chair of the Department of Surgery and Transplantation at the University of Zürich, Switzerland. He serves as Program Director of the HPB Surgery and Liver Transplant Fellowship at the Swiss HPB and Transplant Center Zurich. Dr Petrowsky is heading the Liver and Pancreas Tumor Center, which is embedded in the Comprehensive Cancer Center Zurich at the University Hospital Zurich. His current practice consists of liver transplantation and HPB surgery. His research interests have mirrored his clinical work mainly focusing on translational and outcome research in liver transplantation and hepatobiliary surgery.
Dr Petrowsky received his medical degree from the Johann Wolfgang Goethe University in Frankfurt, Germany. He spent a two-year research fellowship at Memorial Sloan-Kettering Cancer Center in New York and completed his training in general surgery and hepatobiliary surgery at The University Hospital in Zurich, Switzerland. In 2009, he completed the Multi-Organ Transplant Fellowship at the University of California Los Angeles and joined the faculty of University of California Los Angeles as Assistant Professor of Surgery-in-Residence and liver transplant attending.